Clinical Trials · NCT00902655

Desmopressin in the Treatment of Mixed Nocturia With Nocturnal Polyuria and Low Nocturnal Bladder Capacity

Name: Desmopressin in the Treatment of Mixed Nocturia With Nocturnal Polyuria and Low Nocturnal Bladder Capacity
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 4Desmopressin

Phase: Phase 4
Recruitment status: Completed
Sponsor: Samsung Medical Center
Enrollment: 103
Start date: Apr 2004
Locations: 6 sites, South Korea
Primary endpoint: Proportion of patients with a 50% or greater reduction in the mean number of nocturnal voids compared with baseline levels.

View Desmopressin compound reference